CellCept ® (mycophenolate mofetil) is indicated for the prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac or hepatic transplants. CellCept should be used concomitantly with cyclosporine and corticosteroids.
CellCept Intravenous is an alternative dosage form to CellCept capsules, tablets and oral suspension. CellCept Intravenous should be administered within 24 hours following transplantation. CellCept Intravenous can be administered for up to 14 days; patients should be switched to oral CellCept as soon as they can tolerate oral medication.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using CellCept and call your doctor at once if you have any of these serious side effects:
fever, chills, body aches, flu symptoms;
pale skin, easy bruising or bleeding, unusual weakness, trouble breathing, fast heart rate;
coughing up blood or vomit that looks like coffee grounds;
bloody, black, or tarry stools;
painful or difficult urination;
chest pain; or
feeling like you might pass out;
problems with vision, speech, balance, or memory; or
weakness in your legs, lack of coordination.
Less serious Cellcept side effects may include:
nausea, vomiting, stomach pain, diarrhea, or constipation;
headache, mild weakness;
swelling in your hands or feet;
numbness or tingly feeling; or
anxiety, sleep problems (insomnia).
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect.